Company profile
Abalos Therapeutics company profile
The company intends to use the funds to advance its arenavirus-based lead candidates towards clinical testing. They will develop the initial product candidates using its proprietary Fast Evolution platform, which will generate virus strains with optimized anti-tumoral properties. These candidates will be selected based on their ability to re-program the immune system to specifically and efficiently eliminate the malignant tumor tissue.
Business identity
- Website
- https://abalos-tx.com/
- Contact email
- [email protected]
- Phone number
- +49 201 565 787-00
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00011-00050 employees
- Revenue range
- $1K+
- Founded
- 2005-01-01
Headquarters
- Headquarters
- Gandesbergen, Lower Saxony, Germany
- Postal code
- 45130
- Country code
- DE
- Continent
- Europe